![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/31/2921965/22558/en/BioSig-Technologies-Announces-Intent-to-Acquire-the-Assets-of-Neuro-Kinesis-Corporation.html
https://www.globenewswire.com/news-release/2024/07/25/2919137/22558/en/BioSig-Technologies-Improves-Balance-Sheet-Announces-Reduction-in-Outstanding-Payables-during-Q2-2024.html
https://www.globenewswire.com/news-release/2024/06/10/2896092/22558/en/BioSig-Technologies-Appoints-Mr-Ferdinand-Groenewald-to-Position-of-Interim-Chief-Financial-Officer-and-Principal-Accounting-Officer.html
https://www.globenewswire.com/news-release/2024/05/30/2890718/22558/en/BioSig-Announces-3-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/05/30/2891122/22558/en/BioSig-Announces-Closing-of-3-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/05/21/2885826/22558/en/BioSig-Technologies-Chief-Executive-Officer-Mr-Anthony-Amato-Issues-the-Following-Letter-to-Shareholders.html
https://www.globenewswire.com/news-release/2024/05/03/2875283/22558/en/BioSig-Technologies-Inc-Announces-New-Appointments-to-its-Now-Fully-Constituted-Board-of-Directors-which-is-Comprised-of-5-Board-Members-3-Independent.html
https://www.globenewswire.com/news-release/2024/04/30/2872692/22558/en/BioSig-Technologies-Inc-Appoints-Mr-Anthony-Amato-to-Position-of-Chief-Executive-Officer-Effective-Immediately.html
https://www.globenewswire.com/news-release/2024/04/04/2858000/22558/en/BioSig-Engages-Consulting-Firm-for-Business-Model-Strategies.html
https://www.globenewswire.com//news-release/2024/02/20/2832018/22558/en/BioSig-Announces-Reduction-of-its-Workforce.html